INFUSIO®, a European Cellular Therapy Clinic, Announces New Management

BEVERLY HILLS, Calif., Sept. 19, 2018 /PRNewswire-PRWeb/ -- INFUSIO® in Beverly Hills, California, and Frankfurt, Germany, has entrusted Global Synergy Health (GSH), a Florida-based management company, with expanding the company's operations and reestablishing its core values of Foundational Health, Empathy, and Patient Empowerment. Marco Gallo, Director of GSH, says what patients can expect: "Under our new management, Infusio will implement changes to its Lyme and Cancer Programs that will yield increased benefits to patients. These changes include a price reduction in the Lyme and Tick-Borne Disease Program, as well as a partnership with Onkologikum Frankfurt, a world-class practice of oncology, endocrinology, and hematology, just to mention a few. We are very honored to take this treatment concept global and create awareness for new and innovative treatment options."

INFUSIO® was established in Germany in 2011 and opened its first treatment center in the U.S. in 2014. The Foundational Medicine approach combines traditional European medicine, integrative medicine, and cutting-edge science to treat complex and multi-faceted chronic diseases. The concept was designed by Philip Battiade, a British born Naturopath with two decades of experience in cellular therapies and chronic degenerative disease treatment.

The INFUSIO® concept is based on Battiade's "Five Steps to Health" which includes Immune Modulation, Cellular Optimization, Detoxification, Disease-Specific Treatment, and Mind-Body Medicine. The treatments range from various IV therapies, oxygen therapies to immune therapies, laser therapies, bodywork, and stem cell-based therapies. Usually, a two- or four-week regiment is administered under the supervision of a medical doctor in one of the Infusio treatment centers. In addition to that, Battiade has taken medicine out of the doctor's office and placed it into a spa-like ambiance to create a healing environment in which patients feel safe.

More details on treatment program enhancements and added services are expected to be released within the following weeks on Infusio's website.

Contact Infusio for more information on the latest research in cancer and tick borne disease and available treatments. To learn more about stem cell-based therapies and foundational medicine visit infusio.org or infusiobeverlyhills.com.

SOURCE Infusio